The congress is set to bridge the gap between regulatory bodies, industry professionals and academic representatives to drive pharmacovigilance operations forward

Big data and AI in pharmacovigilance Benefit-risk management strategies and patient-centric approaches Challenges of drug safety legislation globally

Ensuring patient safety Technology (AI, IoT, Big Data) BREXIT implications Safety signal detection patient centric Click here to get more information: https://www.virtueinsight.com/pharma/27th-Pharmacovigilance-2022/